ANI Pharmaceuticals has been granted a patent for a method of storing and warming a sterile corticotropin composition in a multiple-dose vial with specific temperature requirements and composition details. GlobalData’s report on ANI Pharmaceuticals gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on ANI Pharmaceuticals, was a key innovation area identified from patents. ANI Pharmaceuticals's grant share as of May 2024 was 67%. Grant share is based on the ratio of number of grants to total number of patents.
Method of storing and warming sterile corticotropin composition
A recently granted patent (Publication Number: US11975047B1) discloses a method for storing and warming a sterile corticotropin composition. The method involves storing the composition in a multiple-dose vial with specific temperature conditions and warming it to a different temperature range. The corticotropin composition includes amino acids 1-39 of SEQ ID NO: 1 and must have limited Vasopressin Units. Additionally, the composition may contain phenol, gelatin, water, hydrochloric acid, and sodium hydroxide, with a pH range of 3.0-7.0.
Furthermore, the patent claims cover various aspects of the storage and warming process, including the physical properties of the composition, the materials used in the vial construction, and the absence of certain substances like acetic acid. The method also includes injecting the sterile corticotropin composition into human subjects for conditions such as multiple sclerosis, gouty arthritis, psoriasis, atopic dermatitis, rheumatoid arthritis, or allergic conjunctivitis. Overall, the patent provides a detailed and specific protocol for handling this corticotropin composition to ensure its efficacy and safety when administered to patients.
To know more about GlobalData’s detailed insights on ANI Pharmaceuticals, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies
